ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "fibromyalgia"

  • Abstract Number: 867 • 2012 ACR/ARHP Annual Meeting

    Events That Trigger  the Onset of the Fibromyalgia Syndrome (FMS)

    Robert S. Katz1, Sharon M. Ferbert2, Alexandra Small3 and Susan Shott1, 1Rush University Medical Center, Chicago, IL, 2Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL, 3University of Illinois Medical School, Chicago, IL

    Background/Purpose: Triggering events – those that are followed by the onset or rapid increase in FMS symptoms – have a significant impact in some cases. …
  • Abstract Number: 2646 • 2012 ACR/ARHP Annual Meeting

    Cost-Effectiveness of Tai Chi Mind-Body Exercise for the Treatment of Fibromyalgia

    John B. Wong1 and Chenchen Wang2, 1Medicine/Clinical Decision Making, Tufts Medical Center, Boston, MA, 2Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose:   Although fibromyalgia is associated with substantial annual direct medical and indirect productivity costs, the cost-effectiveness of treatments for fibromyalgia remains understudied. A randomized…
  • Abstract Number: 1868 • 2012 ACR/ARHP Annual Meeting

    Clinical Outcome in Fibromyalgia Patients Treated with Milnacipran Is Largely Independent of Symptom Duration

    Philip J. Mease1, Robert M. Bennett2, Robert H. Palmer3 and Yong Wang4, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Medicine & Nursing, Oregon Health & Science University, Portland, OR, 3Forest Research Institute, Inc., Jersey City, NJ, 4Forest Research Institute, Jersey City, NJ

    Background/Purpose: Patients with fibromyalgia (FM) usually experience pain, fatigue, and other debilitating symptoms for years. In clinical studies ranging from 3 months to >3 years,…
  • Abstract Number: 802 • 2012 ACR/ARHP Annual Meeting

    Milnacipran Reduces Brain Activity During Pain in Fibromyalgia

    Anson E. Kairys1, Richard E. Harris2, Eric Ichesco2, Johnson P. Hampson2, Steven Harte2, Daniel J. Clauw3 and Tobias Schmidt-Wilcke2, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

    Background/Purpose: Fibromyalgia (FM) is a chronic pain condition characterized by widespread musculoskeletal pain and a number of concomitant symptoms such as fatigue, sleep disturbance, cognitive…
  • Abstract Number: 1875 • 2012 ACR/ARHP Annual Meeting

    A Patient and Physician Survey of Impact and Management of Fibromyalgia Across Latin America and Europe

    Patricia Clark, Unidad de Epidemilogia Clinica, Hospital Infantil de México Federico Gómez, Mexico City, Mexico

    Background/Purpose: Differences in healthcare practices around the world have been reported; however any impact on management of chronic conditions is often unclear. We surveyed patients…
  • Abstract Number: 803 • 2012 ACR/ARHP Annual Meeting

    Frontal Brain Connectivity to the Default Mode Network Is Associated with Subjective Fatigue Irrespective of Pain and Depression

    Johnson P. Hampson1, Daniel J. Clauw2, Jieun Kim3, Vitaly Napadow4 and Richard E. Harris1, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 3Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, 4Radiology, Martinos Center for Biomedical Imaging, Charlestown, MA

    Background/Purpose: Chronic pain patients report increased levels of fatigue; however, very little is known about the underlying mechanisms of this symptom. Previous work by our…
  • Abstract Number: 2641 • 2012 ACR/ARHP Annual Meeting

    Time-to-Improvement of Pain and Sleep in Clinical Trials of Pregabalin Treatment of Fibromyalgia

    Lesley M. Arnold1, Andrew Clair2, Birol Emir2, Lynne Pauer2 and E. Malca Resnick2, 1Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, 2Pfizer Inc, New York, NY

    Background/Purpose: Fibromyalgia (FM) is a chronic condition characterized by widespread pain and tenderness. Sleep disturbance is common in patients with FM, and both pain and…
  • Abstract Number: 1857 • 2012 ACR/ARHP Annual Meeting

    Identifying Core Symptom Domains in the Fibromyalgia Impact Questionnaire: Principal Component Analysis of Data From Milnacipran Clinical Studies

    Philip J. Mease1, Robert M. Bennett2, Robert H. Palmer3 and Yong Wang4, 1Swedish Medical Center and University of Washington, Seattle, WA, 2Medicine & Nursing, Oregon Health & Science Univ, Portland, OR, 3Forest Research Institute, Inc., Jersey City, NJ, 4Forest Research Institute, Jersey City, NJ

    Background/Purpose: The Fibromyalgia Impact Questionnaire (FIQ) is a multidimensional instrument that encompasses many of the core domains recommended by OMERACT for evaluation in fibromyalgia (FM)…
  • Abstract Number: 804 • 2012 ACR/ARHP Annual Meeting

    A Comparison of the Nociceptive Flexion Reflex, Pressure Algometry and Summated Widespread Pain in the Diagnosis of Fibromyalgia

    Robert M. Bennett1, Kim D. Jones2 and Janice Hoffman3, 1Medicine & Nursing, Oregon Health & Science Univ, Portland, OR, 2Research & Develop, Oregon Health Sciences University, Portland, OR, 3Office of Research Development & Support, Oregon Health & Science University, Portland, OR

    Background/Purpose: To reevaluate the usefulness of the nociceptive flexion reflex (NFR) in distinguishing between FM patients and healthy controls, compared to computerized algometry and a…
  • Abstract Number: 2644 • 2012 ACR/ARHP Annual Meeting

    Functional Magnetic Resonance Imaging of Working Memory in Fibromyalgia: Support for a “Competing Demands” Theory of Cognitive Function in Chronic Pain

    Anson E. Kairys1, Gabriela Ramirez1, Eric Ichesco2, Johnson P. Hampson2, Richard E. Harris2, Daniel J. Clauw3, Tobias Schmidt-Wilcke2 and Jennifer M. Glass4, 1Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Anesthesiology, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 4Psychiatry, University of Michigan, Ann Arbor, MI

    Background/Purpose: The primary symptom of fibromyalgia (FM) is chronic widespread pain; however, patients report additional symptoms including decreased concentration and memory. Deficits are seen mainly…
  • Abstract Number: 1858 • 2012 ACR/ARHP Annual Meeting

    Hypervigiliance in Fibromyalgia

    Robert S. Katz1, Ben J. Small2, Susan Shott1 and Sharon M. Ferbert3, 1Rush University Medical Center, Chicago, IL, 2MacNeal Hospital, Berwyn, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL

    Background/Purpose: Patients with fibromyalgia syndrome (FMS) experience severe chronic pain and usually are tender to touch. They are hyperactive to weather changes and stress. Do…
  • Abstract Number: 805 • 2012 ACR/ARHP Annual Meeting

    Milnacipran Increases Cortical to Brainstem Connectivity During Pain in Fibromyalgia

    Eric Ichesco1, Tobias Schmidt-Wilcke1, Anson E. Kairys2, Johnson P. Hampson1, Steven E. Harte1, Daniel J. Clauw3 and Richard E. Harris1, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 3Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI

    Background/Purpose: Fibromyalgia (FM) is a chronic widespread pain disorder characterized by muscle tenderness, fatigue, poor sleep, and mood disturbance.  Milnacipran is a dual serotonin-norepinephrine reuptake…
  • Abstract Number: 2450 • 2012 ACR/ARHP Annual Meeting

    Evoked Pain Brain Response Is Associated with Reduced μ-Opioid Receptor Binding in Fibromyalgia

    Heng Wang1, Daniel J. Clauw2, Jon-Kar Zubieta3 and Richard E. Harris4, 1Anesthesiology, University of Michigan, Ann Arbor, 2Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 3Molecular and Behavioral Neuroscience Institue, Psychiatry, University of Michigan, Ann Arbor, 4Anesthesiology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Previous studies indicate that fibromyalgia (FM) patients have augmented clinical and brain responses to painful stimuli (i.e. hyperalgesia/allodynia), as well as increased production of…
  • Abstract Number: 1566 • 2012 ACR/ARHP Annual Meeting

    Fibromyalgia’s Impact On Relationships

    Robert S. Katz1, Alexandra Small2, Sharon M. Ferbert3 and Susan Shott1, 1Rush University Medical Center, Chicago, IL, 2University of Illinois Medical School, Chicago, IL, 3Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL

    Background/Purpose: The Fibromyalgia Syndrome (FMS) can place a strain on patients’ personal relationships. Having a close support network is helpful in coping with illnesses, but chronic…
  • Abstract Number: 806 • 2012 ACR/ARHP Annual Meeting

    Posterior Insula Combined Glutamate and Glutamine Is Associated with Pain in Fibromyalgia: A Replication Study

    Eric Ichesco1, Daniel J. Clauw2, Steven E. Harte1, Anson E. Kairys3, Johnson P. Hampson1, Tobias Schmidt-Wilcke1 and Richard E. Harris1, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, 3Department of Anesthesiology, Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI

    Background/Purpose: Central pain augmentation resulting from enhanced excitatory and/or decreased inhibitory neurotransmission is a proposed mechanism underlying the pathophysiology of functional pain syndromes such as…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology